(Q36147870)

12 August 2017

Clinic-based retrospective analysis of psychopharmacology for behavior in fragile x syndrome (English)

1 reference

12 August 2017

1 reference

Elizabeth Berry-Kravis

1

1 reference

12 August 2017

Allison Sumis

2

1 reference

12 August 2017

Crystal Hervey

3

1 reference

12 August 2017

Shaguna Mathur

4

1 reference

12 August 2017

30 July 2012

1 reference

International Journal of Pediatrics

12 August 2017

1 reference

12 August 2017

2012

1 reference

12 August 2017

843016

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Targeted treatments for fragile X syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Open-label add-on treatment trial of minocycline in fragile X syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Therapeutic implications of the mGluR theory of fragile X mental retardation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Psychopharmacology in fragile X syndrome--present and future

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Risperidone in children with autism and serious behavioral problems

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Aberrant behaviors of young boys with fragile X syndrome.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Imipramine treatment of ADHD in a fragile X child.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Absence of expression of the FMR-1 gene in fragile X syndrome

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Fluoxetine Treatment of Children and Adults with Autistic Disorder and Mental Retardation

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Physical characteristics of young boys with fragile X syndrome: reasons for difficulties in making a diagnosis in young males.

2 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Open-label memantine in fragile X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

A prospective open-label study of aripiprazole in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Influence of stimulants on electrodermal studies in Fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Long-term follow-up of children with mental retardation/borderline intellectual functioning and ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Brief report: acamprosate in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F843016

Fragile X syndrome and selective mutism.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3413981

Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22899942

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A controlled trial of stimulant medication in children with the fragile X syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22899942

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prevalence of fragile X syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22899942

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2012/843016

1 reference

12 August 2017

1 reference

12 August 2017

1 reference